Clinical trial
A Study to Evaluate the Efficacy of an RSV F Vaccine in Older Adults
NCT02608502 is registered in ClinicalTrials.gov with Novavax as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study to Evaluate the Efficacy of an RSV F Vaccine in Older Adults
- Lead sponsor
- Novavax
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- November 30, 2015
- Completion date
- December 31, 2016
- Enrollment
- 11,850 (actual)
- Sites
- 60
Conditions
As the registry lists them; a condition with its own page is linked.
respiratory syncytial virus (rsv)